Research6d ago
Research
ML Finds New HER2 Cancer Drug
The study screened 1,200 drugs and identified 12 FDA‑approved candidates that inhibit HER2 signaling. Researchers used a graph‑based neural network to predict drug‑target interactions. The findings, published in Nature, suggest a rapid path to clinical trials for these repurposed agents. Practitioners can prioritize trials for hits in the next phase.